Joint Sales Calls Sample Clauses

The Joint Sales Calls clause establishes the terms under which representatives from both parties may collaborate to conduct sales presentations or meetings with potential or existing customers. Typically, this clause outlines the procedures for coordinating such joint efforts, including scheduling, roles during the call, and sharing of customer information. Its core practical function is to facilitate effective cooperation between the parties in pursuing sales opportunities, while also clarifying expectations and responsibilities to prevent misunderstandings or conflicts during joint sales activities.
Joint Sales Calls. Upon mutual agreement, proper advance planning and identification of suitable prospects, The ▇▇▇▇▇▇▇▇ Trust and ▇▇▇▇▇▇▇▇ shall make sales calls in the Territory jointly with NTI and/or the Company sales staff to promote the sale of Products or Services utilizing the Polymer Recycling Technology in the Territory.
View SourceView Similar (3)
Joint Sales Calls. Two (2) NTI employees shall participate with ----------------- Cadence in sales calls for up to three (3) weeks per quarter, made to prospective customers for the Cadence Combined Products during the Initial Term and any Renewal Term.
View SourceView Similar (2)
Joint Sales Calls. Upon mutual agreement, proper advance planning and identification of suitable prospects, NTI management shall make sales calls in the Territory with the Company’s sales staff to promote the Product.
View SourceView Similar (2)
Joint Sales Calls. During each Contract Year, Carrier shall conduct joint sales calls with Worldspan to Target Accounts as mutually agreed by Carrier and Worldspan; provided, however, that, in each case, Carrier’s agreement to conduct such calls shall not be unreasonably withheld.
View SourceView Similar (2)
Joint Sales Calls. If agreed upon by Atrium and Collaborent, each Party will allocate resource(s) to attend joint sales calls on an agreed upon basis to pursue Prospective Participants and joint sales opportunities.
View SourceView Similar (2)
Joint Sales Calls. Suppliers ----------------------------- (a) VWR and Chemdex shall cooperate to jointly solicit suppliers in the laboratory supplies and equipment industry to distribute, market and sell products through the System. It is anticipated that those suppliers that currently supply products through Chemdex will continue to do so and that those suppliers that currently supply products through VWR will continue to do so.
View Source
Joint Sales Calls. For purposes of this Agreement, a Joint Sales Call is a meeting with a representative of a logic simulation customer of Zycad and an IKOS representative and a Zycad representative. The balance of $500,000 shall be payable by IKOS by wire transfer within three (3) days after receipt of notice from Zycad of completion of an additional twenty-five (25) Joint Sales Calls.
View Source

Related to Joint Sales Calls

  • Product Sales Subject to Sections 10.3(c) and 10.3(d), Licensee agrees that it will not sell, offer for sale, or assist third parties (including Affiliates) in selling Product except for the sale and offer for sale of (A) TAF Product, TAF Combination Product, TDF Product and TDF Combination Product for use in the Field and in the countries of the TDF-TAF Territory, (B) COBI Product and COBI Combination Product for use in the Field and in the countries of the COBI Territory, and (C) EVG Product, EVG Combination Product and Quad Product for use in the Field and in the countries of the EVG-Quad Territory.‌ (i) Licensee agrees that during the period in which the Patents are valid and enforceable (on a Product-by-Product basis) it will prohibit its Distributors from selling Product (A) to any other wholesaler or distributor, (B) outside the Territory for which Licensee is licensed for sale of such Product pursuant to Section 2.2, or (C) for any purpose outside the Field. (ii) Licensee agrees that it will not administer the TAF Quad to humans, or sell the TAF Quad until Gilead has obtained marketing approval for the TAF Quad from the FDA. Licensee agrees that it will not administer EVG to humans, or sell Products containing EVG until Gilead has obtained marketing approval for an EVG Product from the FDA. Licensee agrees that it will not administer COBI to humans, or sell Products containing COBI until Gilead has obtained marketing approval for a COBI Product from the FDA. Licensee agrees that it will not administer TAF to humans, or sell Products containing TAF until Gilead has obtained marketing approval for a TAF Product from the FDA. If Gilead obtains marketing approval from the FDA for any Quad Product or a Combination Product containing TAF, COBI or EVG (“Approved Combination Product”) prior to obtaining marketing approval for a TAF Product, EVG Product or COBI Product from the FDA, then Licensee will be allowed to administer such Quad Product or such Approved Combination Product to humans, and sell such Quad Product or such Approved Combination Product from and after the date of such marketing approval from the FDA, but will not (A) administer to humans or sell Combination Products containing EVG other than such Quad Product or such Approved Combination Product until Gilead has obtained marketing approval from the FDA for an EVG Product, or (B) administer to humans or sell Combination Products containing COBI other than such Quad Product or such Approved Combination Product until Gilead has obtained marketing approval from the FDA for a COBI Product or (C) administer to humans or sell Combination Products containing TAF other than such Quad Product or such Approved Combination Product until Gilead has obtained marketing approval from the FDA for a TAF Product.

  • Direct Sales The Manager will advise you promptly, on the Offering Date, as to the Securities purchased by you pursuant to the Underwriting Agreement that you will retain for direct sale. At any time prior to the termination of the applicable AAU, any such Securities that are held by the Manager for sale but not sold may, on your request and at the Manager’s discretion, be released to you for direct sale, and Securities so released to you will no longer be deemed held for sale by the Manager. You may allow, and Dealers may reallow, a discount on sales to Dealers in an amount not in excess of the Reallowance set forth in the applicable AAU. You may not purchase Securities from, or sell Securities to, any other Underwriter or Dealer at any discount or concession other than the Reallowance, except with the prior consent of the Manager.

  • Contract Quarterly Sales Reports The Contractor shall submit complete Quarterly Sales Reports to the Department’s Contract Manager within 30 calendar days after the close of each State fiscal quarter (the State’s fiscal quarters close on September 30, December 31, March 31, and June 30). Reports must be submitted in MS Excel using the DMS Quarterly Sales Report Format, which can be accessed at ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇▇▇▇▇▇▇▇.▇▇▇/business_operations/ state_purchasing/vendor_resources/quarterly_sales_report_format. Initiation and submission of the most recent version of the Quarterly Sales Report posted on the DMS website is the responsibility of the Contractor without prompting or notification from the Department’s Contract Manager. If no orders are received during the quarter, the Contractor must email the DMS Contract Manager confirming there was no activity.

  • Field Trips Orange COUNTY funds may not be used to support any overnight and/or out of Central Florida travel, unless approved by the COUNTY’S Manager of the CCC or designee in advance. The AGENCY must have on file for field trip(s) that each participant, adult or minor, must have a signed release of liability form releasing the COUNTY from any liability. If the participant is a minor, the release must be signed by a parent/guardian. Central Florida is defined as Orange, Osceola, Seminole, Brevard, Lake, Polk, and Volusia Counties.

  • Contract Sales Price The total consideration provided for in the sales contract for the sale of a Property.